Engineering Germline‑Style Purifying Selection into Somatic Stem Cells to Curb Age‑Related Mosaic Chromosomal Alterations

Chen Kato· Mar 21, 2026

Mechanism: A synthetic CNV sensor in somatic stem cells detects chromosomal duplications, activating a BAX-mediated apoptosis pathway to eliminate aberrant cells. Readout: Readout: This reduces mosaic chromosomal alterations, lowers clonal hematopoiesis, and increases expected lifespan by 50%.

Hypothesis

Somatic tissues can be protected from age‑related mosaic chromosomal alterations (mCAs) by imposing germline‑style purifying selection through inducible, copy‑number‑sensing apoptotic circuits in stem/progenitor compartments.

Rationale

The germline prevents transmission of CNVs by continuously eliminating aberrant oocytes and spermatocytes via meiotic checkpoints and apoptosis[PMC6699064].
Somatic lineages lack this generational filter, allowing replication‑fork stalling, NAHR near segmental duplications, and telomere attrition to generate mCAs that accumulate with age[aging-us.com/article/101461/text].
Clonal hematopoiesis driven by mCAs exemplifies the pathogenic potential of unchecked somatic mosaicism[PMC6699064] and is linked to cancer and mortality.

Mechanism

We propose engineering a synthetic "CNV sensor" composed of a pair of orthogonal CRISPR‑Cas12a guides targeting conserved sequences flanking common segmental duplications. When a duplication or deletion alters the dosage of these sites, the imbalance in guide RNA binding triggers a split‑TEV protease system that releases a transcriptional activator of BAX, inducing apoptosis specifically in cells bearing the alteration.

This circuit mimics the germline’s ruthless culling: any cell that acquires a CNV suffers a proportional increase in sensor activation and is removed before it can expand clonally.

Testable Predictions

In murine hematopoietic stem cells transplanted with the sensor, longitudinal single‑cell DNA sequencing will show a significantly lower rate of mCA acquisition compared with controls after 12 months of aging (expected reduction >50%).
Mice expressing the sensor will exhibit delayed onset of clonal hematopoiesis (lower VAF of driver mutations such as Dnmt3a) and reduced incidence of age‑related hematologic malignancies.
Senescent markers (p16^Ink4a^, SASP) will be diminished in sensor‑bearing tissues, reflecting reduced proliferative pressure from maladaptive clones.
Conversely, forced inhibition of the sensor (e.g., via doxycycline‑repressible TEV) should rescue the accelerated mCA accumulation, confirming causality.

Falsifiability

If longitudinal sequencing reveals no difference in mCA burden between sensor‑expressing and control animals, or if sensor expression leads to excessive stem‑cell loss and phenotypes of aplastic anemia without reducing mCAs, the hypothesis would be refuted. Additionally, if apoptosis is triggered in CNV‑neutral cells (false positives), the approach would be deemed non‑viable.

Broader Impact

Success would demonstrate that the germline’s strategy of continuous selection can be transplanted to somatic compartments, offering a paradigm shift from damage‑repair to damage‑elimination for mitigating age‑related genomic instability and its comorbidities.

Rationale

The germline prevents transmission of CNVs by continuously eliminating aberrant oocytes and spermatocytes via meiotic checkpoints and apoptosis[PMC6699064].

Somatic lineages lack this generational filter, allowing replication‑fork stalling, NAHR near segmental duplications, and telomere attrition to generate mCAs that accumulate with age[aging-us.com/article/101461/text].

Clonal hematopoiesis driven by mCAs exemplifies the pathogenic potential of unchecked somatic mosaicism[PMC6699064] and is linked to cancer and mortality.

Mechanism

This circuit mimics the germline’s ruthless culling: any cell that acquires a CNV suffers a proportional increase in sensor activation and is removed before it can expand clonally.

Testable Predictions

In murine hematopoietic stem cells transplanted with the sensor, longitudinal single‑cell DNA sequencing will show a significantly lower rate of mCA acquisition compared with controls after 12 months of aging (expected reduction >50%).

Mice expressing the sensor will exhibit delayed onset of clonal hematopoiesis (lower VAF of driver mutations such as Dnmt3a) and reduced incidence of age‑related hematologic malignancies.

Senescent markers (p16^Ink4a^, SASP) will be diminished in sensor‑bearing tissues, reflecting reduced proliferative pressure from maladaptive clones.

Conversely, forced inhibition of the sensor (e.g., via doxycycline‑repressible TEV) should rescue the accelerated mCA accumulation, confirming causality.

Falsifiability